Harmony Biosciences (HRMY) Competitors $37.07 -0.03 (-0.08%) As of 01:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HRMY vs. ROIV, RVMD, GRFS, RYTM, LEGN, ABVX, AXSM, RNA, NUVL, and MRUSShould you be buying Harmony Biosciences stock or one of its competitors? The main competitors of Harmony Biosciences include Roivant Sciences (ROIV), Revolution Medicines (RVMD), Grifols (GRFS), Rhythm Pharmaceuticals (RYTM), Legend Biotech (LEGN), Abivax (ABVX), Axsome Therapeutics (AXSM), Avidity Biosciences (RNA), Nuvalent (NUVL), and Merus (MRUS). These companies are all part of the "pharmaceutical products" industry. Harmony Biosciences vs. Its Competitors Roivant Sciences Revolution Medicines Grifols Rhythm Pharmaceuticals Legend Biotech Abivax Axsome Therapeutics Avidity Biosciences Nuvalent Merus Harmony Biosciences (NASDAQ:HRMY) and Roivant Sciences (NASDAQ:ROIV) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability. Which has better valuation and earnings, HRMY or ROIV? Harmony Biosciences has higher revenue and earnings than Roivant Sciences. Roivant Sciences is trading at a lower price-to-earnings ratio than Harmony Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHarmony Biosciences$714.73M2.97$145.49M$3.1011.91Roivant Sciences$29.05M291.61-$171.98M-$0.70-17.72 Do institutionals and insiders have more ownership in HRMY or ROIV? 86.2% of Harmony Biosciences shares are held by institutional investors. Comparatively, 64.8% of Roivant Sciences shares are held by institutional investors. 23.6% of Harmony Biosciences shares are held by insiders. Comparatively, 10.8% of Roivant Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media refer more to HRMY or ROIV? In the previous week, Roivant Sciences had 3 more articles in the media than Harmony Biosciences. MarketBeat recorded 10 mentions for Roivant Sciences and 7 mentions for Harmony Biosciences. Roivant Sciences' average media sentiment score of 1.58 beat Harmony Biosciences' score of 1.49 indicating that Roivant Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Harmony Biosciences 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Roivant Sciences 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more volatility & risk, HRMY or ROIV? Harmony Biosciences has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, Roivant Sciences has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Is HRMY or ROIV more profitable? Harmony Biosciences has a net margin of 23.44% compared to Roivant Sciences' net margin of -2,111.79%. Harmony Biosciences' return on equity of 26.34% beat Roivant Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Harmony Biosciences23.44% 26.34% 17.71% Roivant Sciences -2,111.79%-15.90%-14.95% Do analysts recommend HRMY or ROIV? Harmony Biosciences currently has a consensus target price of $51.00, suggesting a potential upside of 38.10%. Roivant Sciences has a consensus target price of $16.38, suggesting a potential upside of 32.00%. Given Harmony Biosciences' higher possible upside, research analysts plainly believe Harmony Biosciences is more favorable than Roivant Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Harmony Biosciences 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.20 SummaryHarmony Biosciences beats Roivant Sciences on 11 of the 17 factors compared between the two stocks. Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HRMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HRMY vs. The Competition Export to ExcelMetricHarmony BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.11B$3.11B$5.75B$9.82BDividend YieldN/A2.28%6.66%4.48%P/E Ratio11.8521.0082.2026.53Price / Sales2.97395.17531.05108.84Price / Cash12.5243.5325.7028.92Price / Book2.758.1010.476.55Net Income$145.49M-$53.35M$3.28B$265.93M7 Day Performance-2.94%-0.08%-0.17%-0.58%1 Month Performance7.35%9.38%10.19%6.25%1 Year Performance1.60%10.82%46.75%22.32% Harmony Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HRMYHarmony Biosciences4.2833 of 5 stars$37.07-0.1%$51.00+37.6%+3.1%$2.13B$714.73M11.97200Positive NewsROIVRoivant Sciences3.179 of 5 stars$11.93-0.1%$16.50+38.3%+1.3%$8.15B$29.05M0.00860News CoveragePositive NewsAnalyst ForecastRVMDRevolution Medicines4.4743 of 5 stars$37.97-0.9%$69.92+84.2%-7.3%$7.10B$11.58M0.00250News CoveragePositive NewsGRFSGrifols3.9345 of 5 stars$9.97+1.0%$10.30+3.3%+3.6%$6.85B$7.81B8.5223,822News CoveragePositive NewsRYTMRhythm Pharmaceuticals3.3008 of 5 stars$103.15-1.0%$101.57-1.5%+120.4%$6.85B$130.13M-34.27140News CoveragePositive NewsLEGNLegend Biotech3.5372 of 5 stars$34.73+1.0%$74.22+113.7%-40.5%$6.41B$627.24M0.002,609ABVXAbivax3.2466 of 5 stars$81.03-0.7%$92.33+13.9%+545.1%$6.12BN/A0.0061News CoveragePositive NewsShort Interest ↓AXSMAxsome Therapeutics4.7606 of 5 stars$121.28-0.4%$178.00+46.8%+38.9%$6.05B$385.69M-23.92380Positive NewsAnalyst ForecastInsider TradeRNAAvidity Biosciences3.0621 of 5 stars$46.58-4.1%$67.00+43.8%+7.3%$5.99B$10.90M-13.08190Positive NewsNUVLNuvalent3.2305 of 5 stars$76.58+0.7%$120.80+57.7%-9.7%$5.52BN/A-15.6340News CoveragePositive NewsAnalyst ForecastMRUSMerus2.9895 of 5 stars$65.84-0.4%$88.75+34.8%+30.0%$4.98B$36.13M-11.9737News CoveragePositive News Related Companies and Tools Related Companies Roivant Sciences Alternatives Revolution Medicines Alternatives Grifols Alternatives Rhythm Pharmaceuticals Alternatives Legend Biotech Alternatives Abivax Alternatives Axsome Therapeutics Alternatives Avidity Biosciences Alternatives Nuvalent Alternatives Merus Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HRMY) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRMY Stock Alerts